31
Jul
2017

Whither Experts? A Review of The Death of Expertise and Some Thoughts for Biopharma

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Facing the Consequences of a Misinformation Pandemic
Baseball Comes to Surprise Medical Billing
LivLyme and the Many Hats of Patient Advocacy Organizations
23andMe, the Burden of Knowledge, and the Real Value of Money